543 results on '"Tanosaki, Ryuji"'
Search Results
2. Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
3. 日本輸血・細胞治療学会による「院内細胞治療製品取扱実態調査」における再生医療等製品2022年の現状
4. Usefulness of hematopoietic progenitor cell monitoring to predict autologous peripheral blood stem cell harvest timing: A single-center retrospective study
5. 本邦における造血幹細胞採取等のアフェレーシスの実態調査
6. Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation
7. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia/lymphoma
8. Risk factors for CAR‐T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan
9. LYMPHAPHERESIS FOR CAR-T CELL THERAPY: PREDICTION OF CD3+ CELL COUNTS USING AN AUTOMATED HEMATOLOGY ANALYZER
10. Association of Cumulative Steroid Dose with Risk of Infection after Treatment for Severe Acute Graft-versus-Host Disease
11. Eltrombopag for Treatment of Thrombocytopenia after Allogeneic Hematopoietic Cell Transplantation
12. Thrombocytopenia and Low CD4/CD8 Ratio at Apheresis Along with Prior Bendamustine Use Increase Risk of CAR-T Cell Manufacturing Failure
13. Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood–ocular barrier
14. Impact of Graft-versus-Host Disease on Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Leukemia-Lymphoma Focusing on Preconditioning Regimens: Nationwide Retrospective Study
15. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study
16. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study
17. Comparison of cryoprotectants in hematopoietic cell infusion–related adverse events
18. A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy
19. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study
20. Clinical Results of a Massive Blood Transfusion Protocol for Postpartum Hemorrhage in a University Hospital in Japan: A Retrospective Study
21. Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
22. Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes
23. Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens
24. Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors
25. Impact of T Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen
26. Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome
27. Preengraftment Serum C-Reactive Protein (CRP) Value May Predict Acute Graft-versus-Host Disease and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation
28. Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
29. Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients
30. Prospective studies of allogeneic hema topoietic stem cell transplantation for adult T-cell leukemia-lymphoma
31. Early hematopoietic stem cell transplantation improve treatment outcome of aggressive ATL.
32. Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma
33. Unrelated-Donor Bone Marrow Transplantation with a Conditioning Regimen Including Fludarabine, Busulfan, and 4 Gy Total Body Irradiation
34. Comparable Antileukemia/Lymphoma Effects in Nonremission Patients Undergoing Allogeneic Hematopoietic Cell Transplantation with a Conventional Cytoreductive or Reduced-Intensity Regimen
35. Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
36. Adverse Effects of Cell Free and Concentrated Ascites Reinfusion Therapy (CART) for Malignant Ascites: A Single Institute Experience
37. Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: A Case Report and Review of the Literature
38. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma
39. Bulky disease has an impact on outcomes in primary diffuse large B-cell lymphoma of the breast: a retrospective analysis at a single institution
40. EVANS SYNDROME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWING DEVELOPMENT OF RECIPIENT-DERIVED ANTI-E
41. Hematopoietic cell infusion‐related adverse events in pediatric/small recipients in a prospective/multicenter study
42. Adult T-cell leukemia–lymphoma: current treatment strategies and novel immunological approaches
43. Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation
44. Effect of Conditioning Regimen on the Outcome of Bone Marrow Transplantation from an Unrelated Donor
45. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor
46. Development of Solitary Plasmacytoma in the Internal Auditory Canal and Inner Ear after Allogeneic Hematopoietic Stem Cell Transplantation for Plasma Cell Leukemia
47. T-Cell Large Granular Lymphocyte Leukemia of Donor Origin After Cord Blood Transplantation
48. EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
49. Nutritional Support for Patients Suffering From Intestinal Graft-versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
50. Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.